Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription 09.11.2026 2 Alzheimer Dis Assoc Disord 18 Alzheimers Dement 1 Am J Alzheimers Dis Other Demen 1 Am J Med 1 BMC Neurosci 3 Brain 1 Brain Res 6 Curr Alzheimer Res 1 Exp Neurol 5 J Alzheimers Dis 1 J Neurol 1 Nat Neurosci 3 Neurochem Res 3 Neurology 1 PLoS One 1 Proc Natl Acad Sci U S A 1 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Alzheimer Dis Assoc Disord

1. SY J, Tsiknia A, Sussman BL, Ali N, et al
   Brain Mechanisms Linking Type 2 Diabetes to Alzheimer Disease: A Multimodal Imaging Framework.
   Alzheimer Dis Assoc Disord. 2026 Nov 5. doi: 10.1097/WAD.0000000000000756.
   PubMed         Abstract available
   
   
2. LEDINGHAM D, Sathyanarayana S, Iredale R, Foster V, et al
   Evaluating the Interaction of Alzheimer Biomarker Burden and alpha-Synuclein Status on Cognitive Trajectories in Parkinson Disease: Methodological Challenges and Power Estimates.
   Alzheimer Dis Assoc Disord. 2026 Nov 4. doi: 10.1097/WAD.0000000000000762.
   PubMed         Abstract available
   
   

   
   Alzheimers Dement

3. TRITTSCHUH EH, Scollard P, Crane PK, Choi SE, et al
   Measurement precision matters: Accounting for uncertainty alters estimated memory trajectories across the cognitive spectrum.
   Alzheimers Dement. 2026;22:e71976.
   PubMed         Abstract available
   
   
4. SYRJANEN JA, Figdore DJ, Griswold ME, Wiste HJ, et al
   Validation of plasma biomarker immunoassay-based models for predicting brain amyloid positivity in cognitively impaired individuals.
   Alzheimers Dement. 2026;22:e71946.
   PubMed         Abstract available
   
   
5. VAN EGROO M, Patsyuk Y, Baillet M, Vogt NM, et al
   Locus coeruleus microstructural integrity and sleep disruption in the context of Alzheimer's disease pathology.
   Alzheimers Dement. 2026;22:e71964.
   PubMed         Abstract available
   
   
6. SHISHEGAR R, Dore V, Bourgeat P, Doecke JD, et al
   Optimized amyloid-beta PET centiloid and cognitive cutoffs predict progression from mild cognitive impairment to Alzheimer's dementia.
   Alzheimers Dement. 2026;22:e71892.
   PubMed         Abstract available
   
   
7. MOSS C, Yu L, Arfanakis K, Sood A, et al
   Disease progression in probable limbic-predominant age-related TDP-43 encephalopathy.
   Alzheimers Dement. 2026;22:e71954.
   PubMed         Abstract available
   
   
8. TOWNSEND M
   Push-pull hypothesis of Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71721.
   PubMed         Abstract available
   
   
9. LEVEY AI, Palkowitz AD
   Highlighting TaRget Enablement to Accelerate Therapy Development for Alzheimer's Disease (TREAT-AD) centers.
   Alzheimers Dement. 2026;22:e71962.
   PubMed        
   
   
10. SHIRENOVA S, Biragyn A, Okun E
    Age-linked biological context shapes adaptive immunity in Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71978.
    PubMed         Abstract available
    
    
11. HASE Y, Polvikoski T, Jobson D, Premarion K, et al
    Coronary artery disease and cardiac pathology in cerebral small vessel disease and post-stroke dementia: Implications for Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71979.
    PubMed         Abstract available
    
    
12. VIDONI ED, Morris JK, Weis K, Townley RA, et al
    Accelerated clinical evaluations for Alzheimer's disease: feasibility across specialty and rural care settings.
    Alzheimers Dement. 2026;22:e71944.
    PubMed         Abstract available
    
    
13. KIM D, Ho BC, van Voorst H, Liu Y, et al
    Deep learning-based prediction of regional brain Tau PET burden from MRI.
    Alzheimers Dement. 2026;22:e71911.
    PubMed         Abstract available
    
    
14. TARIOT PN, Dickson SP, Dwyer J, Granda C, et al
    Expert perspectives on the design and communication of endpoints in Alzheimer's disease clinical trials.
    Alzheimers Dement. 2026;22:e71951.
    PubMed         Abstract available
    
    
15. MOSCOSO RIAL A, Leuzy A, Raket LL, Villemagne VL, et al
    Tau positron emission tomography harmonization using the CenTauR approach: General conversion equations, relevant cut-points, and external validation.
    Alzheimers Dement. 2026;22:e71886.
    PubMed         Abstract available
    
    
16. PYUN JM, Park YH, Shade LMP, Fardo DW, et al
    Polygenic risk scores for LATE-neuropathologic change: Implications for clinical utility.
    Alzheimers Dement. 2026;22:e71824.
    PubMed         Abstract available
    
    
17. SHEETS KM, Curran JM, Mielke MM, Zeng X, et al
    Chronic kidney disease and blood-based biomarkers of Alzheimer's disease: the brain in kidney disease study.
    Alzheimers Dement. 2026;22:e71940.
    PubMed         Abstract available
    
    
18. AGUILAR-DOMINGUEZ P, Colceriu CM, Holland TM, Lockhart SN, et al
    Association of neighborhood deprivation with Alzheimer's disease pathology, brain structure, and cognition by race and ethnicity, sex, and APOE epsilon4 status.
    Alzheimers Dement. 2026;22:e71929.
    PubMed         Abstract available
    
    
19. 
    Correction to "Gamma sensory stimulation in mild Alzheimer's dementia: An open-label extension study".
    Alzheimers Dement. 2026;22:e71953.
    PubMed        
    
    
20. AVELAR-PEREIRA B, Spotorno N, Dolado AO, Bali D, et al
    Stable episodic memory and higher education do not influence the rate of Alzheimer's disease pathology as measured by plasma p-tau217.
    Alzheimers Dement. 2026;22:e71920.
    PubMed         Abstract available
    
    

    
    Am J Alzheimers Dis Other Demen

21. AHN J, Lee MB, Kwon OI, Rhee HY, et al
    Conductivity-To-Tissue Volume Ratio: Imaging Biomarker for the Alzheimer's Disease Continuum.
    Am J Alzheimers Dis Other Demen. 2026;41:15333175261502814.
    PubMed         Abstract available
    
    

    
    Am J Med

22. GOETZL EJ
    Current development of therapeutic strategies for Alzheimer's disease.
    Am J Med. 2026 Oct 31:S0002-9343(26)00778-3. doi: 10.1016/j.amjmed.2026.
    PubMed         Abstract available
    
    

    
    BMC Neurosci

23. YANG X, Lyu J, Wang J, Quan Y, et al
    Disentangling global atrophy burden from local structural patterns reveals clinically relevant heterogeneity in mild cognitive impairment.
    BMC Neurosci. 2026;27:54.
    PubMed         Abstract available
    
    

    
    Brain

24. LYU X, Mundada NS, Brown CA, Sadeghpour N, et al
    Medial temporal lobe tau-neurodegeneration mismatch from structural imaging and plasma biomarkers.
    Brain. 2026;149:3890-3904.
    PubMed         Abstract available
    
    
25. GIBSON LL, Suemoto CK, Attems J, Abner EL, et al
    The prevalence of Lewy body pathology across nine international community-based cohorts.
    Brain. 2026;149:3923-3938.
    PubMed         Abstract available
    
    
26. CHEN T, Ahmed RM, Piguet O, Irish M, et al
    Behavioural rigidity as a transdiagnostic marker of nucleus accumbens dysfunction in dementia.
    Brain. 2026 Mar 9:awag095. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Brain Res

27. WANG C, Huang W, Zhang W, Zhang L, et al
    Astragalin ameliorates cognitive dysfunction in Alzheimer's disease model mice: Role of the iron metabolism-autophagy axis.
    Brain Res. 2026 Nov 5:150626. doi: 10.1016/j.brainres.2026.150626.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

28. ULUDAG K
    Designing Memory into the Medicine Box: A Call for Smarter Adherence Tools in Alzheimer's Care.
    Curr Alzheimer Res. 2026 Oct 30. doi: 10.2174/0115672050485058261023050143.
    PubMed         Abstract available
    
    
29. YI J, Tan J, Zhou L, Gong Q, et al
    Identification of an S-nitrosylation-Related Gene Signature for Alzheimer's Disease via Bulk and Single-Cell Transcriptomic Profiling.
    Curr Alzheimer Res. 2026 Oct 20. doi: 10.2174/0115672050499844261012051755.
    PubMed         Abstract available
    
    
30. HE W, Wang Z, Zheng S, Liu F, et al
    Natural Bioactive Compound Combinations in Alzheimer's Disease: Gut-brain Axis and Quantitative Interaction Assessment.
    Curr Alzheimer Res. 2026 Oct 21. doi: 10.2174/0115672050536349261015095008.
    PubMed         Abstract available
    
    
31. KALIDAS N, Panerai RB, Beishon L
    Directional Sensitivity of Dynamic Cerebral Autoregulation in Alzheimer's Disease and Mild Cognitive Impairment.
    Curr Alzheimer Res. 2026 Oct 25. doi: 10.2174/0115672050490972261015102304.
    PubMed         Abstract available
    
    
32. AN X, Cao M, Yi Z, Wang Y, et al
    Multi-Omics Machine Learning Framework Identifies CAPS, NUBPL, and RRBP1 as Hubs Linking Neuroinflammation and Mitophagy in Alzheimer's Disease.
    Curr Alzheimer Res. 2026 Oct 28. doi: 10.2174/0115672050516863261020114159.
    PubMed         Abstract available
    
    
33. WILCZYNSKI K
    AI-Assisted Cross-Dataset Prioritization of Circulating microRNA Candidates for Alzheimer's Disease.
    Curr Alzheimer Res. 2026 Oct 27. doi: 10.2174/0115672050513173261019105444.
    PubMed         Abstract available
    
    

    
    Exp Neurol

34. SANDERS B, Korthauer M, Parihar KS, Ifergan I, et al
    Poly(lactic-co-glycolic acid) immunomodulatory nanoparticles attenuate neuroinflammation and Alzheimer's disease-related pathology in 5xFAD mice.
    Exp Neurol. 2026 Nov 5:116116. doi: 10.1016/j.expneurol.2026.116116.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

35. SIMFUKWE C, An SSA, Youn YC
    Eyes-open resting-state EEG microstate analysis using ratio-normalized parameters across four- and seven-class solutions in healthy controls, mild cognitive impairment, and Alzheimer's disease.
    J Alzheimers Dis. 2026 Nov 1:13872877261501861. doi: 10.1177/13872877261501861.
    PubMed         Abstract available
    
    
36. WANG X, Zhang B, Ma H, Shan A, et al
    Integrated clinical and transcriptomic analysis reveals miRNA-mediated mechanisms linking hearing loss to cognitive decline in Alzheimer's disease.
    J Alzheimers Dis. 2026 Nov 1:13872877261501149. doi: 10.1177/13872877261501149.
    PubMed         Abstract available
    
    
37. YANG L, Zeng J, Ding Y, Li L, et al
    Dry, but not wet, age-related macular degeneration increases Alzheimer's disease risk: Findings from a multidimensional analysis.
    J Alzheimers Dis. 2026 Nov 1:13872877261502863. doi: 10.1177/13872877261502863.
    PubMed         Abstract available
    
    
38. PARKER MA, Klopack ET, Johnson AL, Guo L, et al
    Former versus current smoking among older adults living with Alzheimer's disease, related dementias, and cognitive impairment.
    J Alzheimers Dis. 2026 Nov 2:13872877261500405. doi: 10.1177/13872877261500405.
    PubMed         Abstract available
    
    
39. BLOOM K, Schade RN, Kenney LE, Gertler J, et al
    Location matters: The link between regional white matter hyperintensity burden and subjective cognitive decline in those at risk of Alzheimer's disease.
    J Alzheimers Dis. 2026 Nov 6:13872877261502866. doi: 10.1177/13872877261502866.
    PubMed         Abstract available
    
    

    
    J Neurol

40. LABONTE J, Miner AE, Groh JR, Montoliu-Gaya L, et al
    Leveraging immunoprecipitation mass spectrometry and neuropathology to identify the clinical value of different blood tau species in Alzheimer's disease.
    J Neurol. 2026;273:695.
    PubMed         Abstract available
    
    

    
    Nat Neurosci

41. SHARON O, Chen X, Dude J, Westphal J, et al
    Human tau pathology is associated with lonely, nontraveling slow waves linked to memory impairment.
    Nat Neurosci. 2026;29:2652-2658.
    PubMed         Abstract available
    
    

    
    Neurochem Res

42. KAUR A, Goel RK
    Revealing Pharmacological Target for Comorbid Epilepsy in Alzheimer's Disease: Neurochemical Insights from STZ Mice.
    Neurochem Res. 2026;51:316.
    PubMed         Abstract available
    
    
43. WATKINSON B, Bast T, Williams S, Bourgade K, et al
    Intracerebral Administration of a Novel, Bioactive Peptide Induces a Biochemical Profile in Rat Brain Reminiscent of Alzheimer's Disease.
    Neurochem Res. 2026;51:318.
    PubMed         Abstract available
    
    
44. RAKSHIT D, Mishra A
    7-Hydroxyflavone Attenuates Amyloid-beta-Induced Alzheimer's Disease-Like Pathology Through Modulation of ROS/NLRP3 Inflammasome Signaling.
    Neurochem Res. 2026;51:326.
    PubMed         Abstract available
    
    

    
    Neurology

45. ESTELLER-GAUXAX D, Perez-Millan A, Sarto J, Guillen N, et al
    Plasma P-Tau217 and NfL Longitudinal Changes Across Neurodegenerative Diseases: Impact of alpha-Synuclein in Alzheimer Disease.
    Neurology. 2026;107:e218685.
    PubMed         Abstract available
    
    
46. LORENZON G, Garcia-Lluch G, Coughlan GT, Sindi S, et al
    Reproductive Lifespan and Hormonal Therapy in Relation to Later-Life Neurovascular Health in Community-Dwelling Older Women.
    Neurology. 2026;107:e218706.
    PubMed         Abstract available
    
    
47. MATOS SILVA C, Justo AFO, Ribeiro Paes V, Grinberg LT, et al
    Association of LATE-NC With Neuropathologic Lesions and Cognitive Abilities: A Population-Based Autopsy Study.
    Neurology. 2026;107:e218694.
    PubMed         Abstract available
    
    

    
    PLoS One

48. LI D, Weng X, Huang Y, Yang D, et al
    Unveiling the neuroinflammatory potential of aspartame in Alzheimer's disease: A comprehensive network toxicology and experimental validation approach.
    PLoS One. 2026;21:e0361766.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

49. BREZANI V, Ortega-Ribera M, Rezagholizadeh N, Joshi R, et al
    Hepatocyte-derived exosomal miR-122 mediates liver-to-brain crosstalk and neuroinflammation in alcohol-exposed Alzheimer's disease mice.
    Proc Natl Acad Sci U S A. 2026;123:e2535191123.
    PubMed         Abstract available
    
    

    
    Science

50. BORCHERS S, Mazzini G, Zetterberg H, Clemmensen C, et al
    Obesity pharmacotherapies and cognition.
    Science. 2026;394:633-640.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum